News
EXCLUSIVE: Neuralink dragged into humane testing lawsuit – Timeline of Events
Neuralink has been dragged into a lawsuit by the Physicians Committee for Responsible Medicine against the University of California at Davis. The lawsuit, which is amended from its initial filing date of May 2021, seeks to have UC Davis release images and video of inhumanely-treated test subjects, including monkeys, who died after participating in some trials of Neuralink-sponsored research for the development of neural interface implant devices. We have put together an exclusive timeline of events based on interviews and an examination of over 700 pages of documents that UC Davis was required to turn over to the PCRM.
The Physicians Committee for Responsible Medicine (PCRM) is a nonprofit organization with more than 17,000 doctor members. It filed a formal complaint with the United States Department of Agriculture today, claiming UC Davis and Neuralink staff violated the federal Animal Welfare Act related to experiments performed on 23 monkeys. Neuralink paid more than $1.4 million to UC Davis to carry out the experiments.
The PCRM said in a press release that Neuralink and the University “failed to provide dying monkeys with adequate veterinary care, used an unapproved substance known as “Bioglue” that killed monkeys by destroying portions of their brains, and failed to provide for the psychological well-being of monkeys assigned to the experiment.”
In an exclusive interview with Teslarati earlier today, Jeremy Beckham, MPA, MPH, PCRM’s Research Advocacy Coordinator, said that the lawsuit really intends to open up “basic facts about what Neuralink testing did to the animals.” Beckham said monkeys had their brains mutilated in the experiments. Veterinary records, which were shared with Teslarati by the PCRM, show that UC Davis and Neuralink staff performed invasive and deadly experiments on monkeys to assess the effectiveness of the Neuralink device. The letter sent from the PCRM to the USDA earlier today gives several graphic descriptions of how the test animals were treated.
RELATED:
Neuralink details humane animal treatment during Link v0.9 testing
One animal, known as “Animal 6,” was a 6-year-old macaque monkey who was killed on January 16, 2019. The letter states that, on October 10, 2018, implanted electrodes “were placed using an investigational robot,” then, “attached to skull using titanium implant screws.” The location of the screws began to become infected, according to the letter. By January 14th, “Animal 6” had started to pick at the infected area. Staff euthanized the monkey two days later.
Timeline of Events
PCRM has been working to clarify the situation since September 2020, but a more descriptive timeline of events would clarify how Neuralink, UC Davis, and the PCRM have all combined into this issue.
- May 2017 – The University of California at Davis and Neuralink sign and agree to Non-Disclosure Agreements regarding testing.
- September 2017 – UC Davis and Neuralink officially begin their collaboration to carry out primate experiments at UC Davis facilities. The goal is to develop a brain-machine interface.
- July 2018 – “Animal 4,” an 11-year-old macaque monkey is killed in the Neuralink/UC Davis experiments, according to the complaint. The monkey was “on anti-depressants and had chronic diarrhea and poor appetite.” Additionally, the monkey was observed as “lethargic” and “depressed,” and hunched and passed bloody diarrhea. The monkey eventually died in a deadly procedure on July 20th.
- Also in July 2018 – “Animal 12,” approximately 7-years-old, undergoes a craniotomy and electrode insertion procedure. Records show the animal had “severe clinical adverse effects following the implantation, had poor stool quality, was not eating, and had an eye infection.” Records abruptly ended on July 30th.
- September 2018 – “Animal 21,” a 7-year-old female macaque undergoes an “electrode insertion survivability” procedure using “investigational robotics.” The animal was observed with adverse side effects the following day, including vomiting, gasping, retching, and had little interaction with their environment and observers. The animal was euthanized and had signs of “Bioglue,” an unapproved adhesive, covering the brain.
- December 2018 – “Animal 15,” a 7-year-old female macaque undergoes a craniotomy and recording device implantation. Following the surgery, the area became infected and bloody. The animal was euthanized on March 21, 2019. The performed necropsy shows “remnant electrode threads.”
- January 2019 – “Animal 6,” a 6-year-old macaque monkey is killed as a part of the “experimental design.” Electrodes were secured by screws drilled into the monkey’s skull, and lab staff were forced to “frequently clean” the eroding skin near the monkey’s implant site.
- March 2019 – “Animal 11” is killed at approximately 11-years-old during a terminal procedure. The monkey had an implant placed on the head or brain on December 3rd, 2018, and began experiencing symptoms like a weakened appetite and missing fingers and toes, possibly caused by self-mutilation.
- January 2020 – “Animal 5,” another macaque monkey is killed “inadvertently” by an anticonvulsant. He showed signs of significant weight loss and alopecia.
- July 2020 – Neuralink’s Elon Musk announces that the company will hold an event on August 28th, 2020, to display the progress of the V0.9 device. “Will show neurons firing in real-time on August 28th. The matrix in the matrix,” Musk said in a Tweet.
- Also in July 2020 – Neuralink receives a ‘breakthrough device’ designation from the FDA in July, and the company is working with the agency to make the technology as safe as possible.
- August 2020 – Neuralink unveils the v0.9 device, displaying healthy and functioning pigs. Musk delivers a presentation on the new device, showing the simplified product Neuralink has developed. “It’s like a FitBit in your skull with tiny wires,” Musk half-joked. “I could have it right now and you wouldn’t even know. Maybe I do!” The device is said to be installed without general anesthesia. There will be no bleeding, and no noticeable damage after the device is implanted.
- September 2020 – The PCRM files a California Public Records request, wishing for information regarding UC Davis trials of the Neuralink device. The request is eventually denied in accordance with California State Code 6255(a), which says that the Agency “shall justify withholding any record by demonstrating that the record in question is exempt under express provisions of this chapter or that on the facts of the particular case the public interest served by not disclosing the record clearly outweighs the public interest served by disclosure of the record.”
- October 2020 – “Animal 10,” an 8-year-old macaque monkey, is shipped to Neuralink’s facility in Fremont. The monkey has significant hair loss, had lesions from “unspecified traumas,” and was exhibiting self-mutilating behavior.
- November 2020 – Neuralink severs ties with UC Davis on November 11. Neuralink then moves seven of the remaining monkeys to its facility in Fremont, California. Beckham said that records show 15 of the 23 monkeys used in the research died or were euthanized at UC Davis. The final monkey’s situation is unclear, but it is possible the animal was reassigned to a different project at UC Davis, Beckham said.
- April 2021 – Neuralink releases a YouTube video of “Pager the Monkey” allegedly playing video games with a wireless neural interface. The video features a nine-year-old Macaque named Pager playing “MindPong” while utilizing a Neuralink device.
- May 2021 – PCRM sues the University of California Davis under the California Public Records Act (CPRA) for not releasing records in September 2020. Before the suit reaches a judicial decision, Counsel for the University of California agrees to release 700 pages of information.
- October 2021 – University of California’s General Counsel turns over files including animal testing records and veterinarian reports to PCRM. More than 700 pages of records are turned over.
- February 2022 – PCRM files a separate complaint with the U.S. Department of Agriculture that alleges the information the organization has already received reveals evidence of violations of Federal Animal Welfare laws.
Moving Forward
Beckham maintains that the main point of the newest filing is to have UC Davis turn over photographs and videos that reveal the inhumane treatment of the animals due to the experiments. There are monkeys convulsing, vomiting, and dying in these labs,” Beckham said. “People want to step in line for the first human trials, and they should see this before they commit to that,” he told Teslarati. Neuralink was set for human trials this year, Musk said last year.
Beckham said that these complaints can take a while to work through the legal system. “In my years of being involved with humane testing litigation, I know that these things can take some time. Maybe up to a year,” he said. “It also depends how much they want to fight back.”
Neuralink did not immediately respond to our requests for comment.
Beckham’s full letter to the USDA is available below.
2022-02-10 PCRM USDA Complaint Re UC Davis and Neuralink (No Exhibits) by Joey Klender on Scribd
I’d love to hear from you! If you have any comments, concerns, or questions, please email me at joey@teslarati.com. You can also reach me on Twitter @KlenderJoey, or if you have news tips, you can email us at tips@teslarati.com.
Elon Musk
Elon Musk calls out $2 trillion SpaceX IPO valuation as ‘BS’
In a swift rebuke on X, Elon Musk dismissed reports claiming SpaceX had confidentially filed for an initial public offering targeting a valuation above $2 trillion, labeling the information as unreliable.
Elon Musk is quick to call out any false information regarding him or his companies on his social media platform, known as X.
A recent report that claimed SpaceX was aiming to go public with an IPO in the coming weeks at a massive valuation of $2 trillion was called out by Musk, who referred to it as “BS.”
In a swift rebuke on X, Elon Musk dismissed reports claiming SpaceX had confidentially filed for an initial public offering targeting a valuation above $2 trillion, labeling the information as unreliable.
The exchange highlights ongoing media speculation about the rocket company’s future and Musk’s frustration with what he views as inaccurate financial reporting. The report came from Bloomberg.
Don’t believe everything you read.
Bloomberg publishes bs.
— Elon Musk (@elonmusk) April 3, 2026
The controversy erupted on April 2, 2026, when influencer Mario Nawfal amplified claims from Bloomberg.
The outlet posted that SpaceX had boosted its IPO target valuation above $2 trillion, describing it as potentially one of the largest public offerings in history. Musk challenged the story.
It echoes past instances where Musk has corrected valuation rumors about his companies, emphasizing that speculation often outpaces reality.
Background context adds nuance.
Earlier reports indicated SpaceX had filed confidential IPO paperwork with the U.S. Securities and Exchange Commission, potentially positioning it for a record-breaking debut that could eclipse Saudi Aramco’s 2019 listing.
Initial estimates pegged a possible valuation north of $1.75 trillion, building on a post-merger figure around $1.25 trillion after SpaceX absorbed xAI. A subsequent Bloomberg update claimed advisers were floating figures above $2 trillion to investors, with the offering potentially raising up to $75 billion.
SpaceX remains a private powerhouse. Its achievements include thousands of Starlink satellites providing global broadband, routine Falcon 9 rocket reusability, and a mission to slash launch costs, along with ambitions for Starship to enable Mars colonization.
The company also benefits from government contracts with NASA and the Department of Defense. A public listing could democratize access for retail investors while subjecting SpaceX to greater scrutiny and quarterly reporting pressures.
Critics of the reports point to the confidential nature of filings, which limits verifiable details. Musk has previously downplayed inflated valuations, once calling an $800 billion figure for SpaceX “too high.”
Supporters argue that hype around mega-IPOs, especially amid the ongoing AI fervor, fuels premature narratives that distract from core technical milestones, such as full Starship reusability and Starlink constellation expansion.
The incident reflects broader tensions in tech finance. Anonymous sourcing in valuation stories can drive market chatter and betting activity, yet it risks misinformation.
Bloomberg defended its reporting through multiple articles citing “people familiar with the matter,” but Musk’s blunt dismissal resonated widely on X, with users piling on to question media reliability.
Whether SpaceX ultimately goes public remains uncertain. Musk has teased an IPO tied to Starlink maturity, but priorities center on engineering breakthroughs over Wall Street timelines. For now, the $2 trillion figure joins a list of rumored milestones that Musk insists should be taken with skepticism.
Elon Musk
Elon Musk reveals date of SpaceX Starship v3’s maiden voyage
The announcement arrives after Flight 11 on October 13 of last year, which concluded a busy 2025 testing campaign. Since then, SpaceX has focused on ground testing, including cryoproofing of Ship 39 and preparations for Booster 19, the first V3 Super Heavy.
SpaceX CEO Elon Musk has revealed the timeline for the next Starship launch. It will be the first launch using SpaceX’s revamped design for Starship, as its v3 rocket will take its maiden voyage sooner than many might expect.
Musk announced on April 3 on X that the next Starship flight test, and the first flight of the upgraded v3 ship and booster, is 4 to 6 weeks away. The update signals the end of a nearly six-month hiatus since the program’s last launch.
Elon says the first V3 Starship launch will occur in 4-6 weeks
It will be the first Starship launch since Flight 11 on October 13, 2025 https://t.co/QnnYPTdbUu
— TESLARATI (@Teslarati) April 3, 2026
The upcoming mission, designated as Starship’s 12 integrated flight test (IFT-12), marks a significant milestone. It will be the debut of the v3 configuration, featuring a taller Super Heavy Booster and Starship upper stage. The changes SpaceX has made with the v3 rocket and booster are an increased propellant capacity and the more powerful Raptor 3 engines.
Earlier predictions from Musk in March had pointed to an April timeframe, but the latest timeline now targets a launch window in early to mid-May 2026.
The V3 iteration represents a substantial evolution from previous Starship prototypes. Engineers have optimized the design for improved manufacturability, higher thrust, and greater efficiency. Raptor 3 engines deliver significantly more power while reducing weight and production costs compared to earlier variants.
With these enhancements, SpaceX aims to boost payload capacity toward 200 metric tons to low Earth orbit in a fully reusable configuration — a dramatic leap from the roughly 35-ton target of prior versions. Such capabilities are critical for ambitious goals, including NASA’s Artemis lunar missions and eventual crewed flights to Mars.
The announcement arrives after Flight 11 on October 13 of last year, which concluded a busy 2025 testing campaign. Since then, SpaceX has focused on ground testing, including cryoproofing of Ship 39 and preparations for Booster 19, the first V3 Super Heavy.
Recent activities have involved static fires, activation of the new Pad 2 at Starbase in Boca Chica, Texas, and integration of Raptor 3 engines.
A prior incident with an early V3 booster on the test stand in late 2025 contributed to the delay, necessitating additional assembly and qualification work.
Musk’s timeline updates have become a hallmark of the Starship program, often described with characteristic optimism.
SpaceX’s Starship V3 is almost ready and it will change space travel forever
While past targets have occasionally shifted by weeks, the rapid iteration pace remains impressive. However, don’t be surprised if this timeline shifts again, as Musk has been overly optimistic in the past with not only launches, but products under his other companies, too.
SpaceX continues to refine launch infrastructure, including new propellant loading systems and tower mechanisms designed to support higher cadence operations. A successful V3 flight could pave the way for more frequent tests, tower catches of both booster and ship, and progression toward operational reusability.
The v3 debut is viewed as a transition point for Starship, moving beyond experimental flights toward a system capable of supporting large-scale deployment of Starlink satellites, lunar landers, and interplanetary transport.
Success on IFT-12 would demonstrate not only the new hardware’s performance but also SpaceX’s ability to recover from setbacks and maintain momentum.
As the 4-to-6-week countdown begins, anticipation builds at Starbase. Teams are finalizing vehicle stacking, conducting final pre-flight checks, and preparing for regulatory approvals. The world will be watching to see if Starship V3 can deliver on its promise of transforming humanity’s access to space.
Elon Musk
SpaceX to launch military missile tracking satellites through new Space Force contract
SpaceX wins a $178.5M Space Force contract to launch missile tracking satellites starting in 2027.
The U.S. Space Force awarded SpaceX a $178.5 million task order on April 1, 2026 to launch missile tracking satellites for the Space Development Agency. The contract, designated SDA-4, covers two Falcon 9 launches beginning in Q3 2027, one from Cape Canaveral Space Force Station in Florida and one from Vandenberg Space Force Base in California. The satellites, built by Sierra Space, are designed to bolster the nation’s ability to detect and track missile threats from orbit.
The award falls under the National Security Space Launch Phase 3 Lane 1 program, which Space Force uses to move payloads to orbit on faster timelines and at more competitive prices. “Our Lane 1 contract affords us the flexibility to deliver satellites for our customers, like SDA, more easily and faster than ever before to all the orbits our satellites need to reach,” said Col. Matt Flahive, SSC’s system program director for Launch Acquisition, in the official press release.
SpaceX is quietly becoming the U.S. Military’s only reliable rocket
The SDA-4 contract is the latest in a long string of national security wins for SpaceX. As Teslarati reported last month, the Space Force recently shifted a GPS III satellite launch from ULA’s Vulcan rocket to SpaceX’s Falcon 9 after a significant Vulcan booster anomaly grounded ULA’s military missions indefinitely. That move made it four consecutive GPS III satellites transferred to SpaceX after contracts were originally awarded to its competitor.
This didn’t come without a fight and dates back years. SpaceX originally had to sue the Air Force in 2014 for the right to compete for national security launches, at a time when United Launch Alliance held a near monopoly on the market. Since then, the company has steadily displaced ULA as the dominant provider, and last year the Space Force confirmed SpaceX would handle approximately 60 percent of all Phase 3 launches through 2032, worth close to $6 billion.
With missile defense satellites now part of its launch manifest alongside GPS, communications, and reconnaissance payloads, SpaceX is giving hungry investors something to chew on before its imminent IPO.